Emily’s Entourage has opened its 2026 Translational Grants funding cycle, supporting research with translational potential to develop new therapies for people with cystic fibrosis who do not benefit from CFTR modulators.
Applications are due by November 15, 2026.
Full information on eligibility, research priorities and application requirements is available on the Emily’s Entourage website, here.